featured
Anti-Human Glucocorticoid-Induced Tumor Necrosis Factor Receptor Antibody Alone or With Pembrolizumab in Advanced Solid Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I Study of MK-4166, an Anti-Human Glucocorticoid-Induced Tumor Necrosis Factor Receptor Antibody, Alone or With Pembrolizumab in Advanced Solid Tumors
Clin. Cancer Res 2020 Dec 21;[EPub Ahead of Print], KP Papadopoulos, KA Autio, T Golan, K Dobrenkov, E Chartash, Q Chen, R Wnek, GV LongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.